Evidence map›Paper›PMID 36767516›Full record

ReviewInternational journal of environmental research and public health2023

Early Gastric Cancer: Update on Prevention, Diagnosis and Treatment.

Clara Benedetta Conti, Stefano Agnesi, Miki Scaravaglio, Pietro Masseria, Marco Emilio Dinelli, Massimo Oldani, Fabio Uggeri

Open access · goldAbstract readReview
In one paragraph

Review in International journal of environmental research and public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 105 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
105citing papers in PubMed, 4 pooled it
40.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

105 citing papers in PubMed, 4 syntheses or guidelines pooled it, 158 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Rethinking Oxidative Stress inLife (Basel, Switzerland) · 2026
    Review
  10. Observational
  11. Article
  12. Prevention of Gastric Cancer.Medicina (Kaunas, Lithuania) · 2026
    Review
  13. Antibody-drug conjugates in gastric cancer: clinical advances and resistance mechanisms.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2026
    Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

45 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Clara Benedetta ContiInterventional Endoscopy, Foundation IRCCS San Gerardo dei Tintori, 20900 Monza, Italy.ORCID 0000-0001-9774-2374
Stefano AgnesiDepartment of Surgery and Translational Medicine, Foundation IRCCS San Gerardo dei Tintori, University of Milano-Bicocca, 20900 Monza, Italy.ORCID 0000-0002-7472-2669
Miki ScaravaglioInterventional Endoscopy, Foundation IRCCS San Gerardo dei Tintori, 20900 Monza, Italy.
Pietro MasseriaDepartment of Surgery and Translational Medicine, Foundation IRCCS San Gerardo dei Tintori, University of Milano-Bicocca, 20900 Monza, Italy.ORCID 0000-0001-9603-9265
Marco Emilio DinelliInterventional Endoscopy, Foundation IRCCS San Gerardo dei Tintori, 20900 Monza, Italy.ORCID 0000-0003-0214-0333
Massimo OldaniGeneral Surgery Unit, Foundation IRCCS San Gerardo dei Tintori, 20900 Monza, Italy.
Fabio UggeriDepartment of Surgery and Translational Medicine, Foundation IRCCS San Gerardo dei Tintori, University of Milano-Bicocca, 20900 Monza, Italy.ORCID 0000-0002-2209-3602
Azienda Ospedaliera San Gerardo · ITUniversity of Milano-Bicocca · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gastric cancer (GC) is a relevant public health issue as its incidence and mortality rates are growing worldwide. There are recognized carcinogen agents, such as obesity, tobacco, meat, alcohol consumption and some dietary protective factors. Strategies of early diagnosis through population-based surveillance programs have been demonstrated to be effective in lowering the morbidity and mortality related to GC in some countries. Indeed, the detection of early lesions is very important in order to offer minimally invasive treatments. Endoscopic resection is the gold standard for lesions with a low risk of lymph node metastasis, whereas surgical mini-invasive approaches can be considered in early lesions when endoscopy is not curative. This review outlines the role of lifestyle and prevention strategies for GC, in order to reduce the patients' risk factors, implement the surveillance of precancerous conditions and, therefore, improve the diagnosis of early lesions. Furthermore, we summarize the available treatments for early gastric cancer.

Indexed as

Stomach NeoplasmsEarly Detection of CancerEndoscopy, GastrointestinalHumansLife StyleRisk Factorsearly gastric cancerendoscopic submucosal dissectiongastric cancerHelicobacter pyloriupper endoscopy

Identifiers

PMID36767516
PMCPMC9916026
OpenAlexW4318042053

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.